NCT03991936View on ClinicalTrials.gov

Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

March 29, 2023

Study Completion Date

March 29, 2023

Conditions
Nail PsoriasisNail Diseases
Interventions
DRUG

Placebos

Normal saline intralesional injection

DRUG

Triamcinolone Acetonide 2.5 mg/mL

2.5 mg/mL intralesional injection

DRUG

Triamcinolone Acetonide 5.0 mg/mL

5.0 mg/mL intralesional injection

DRUG

Triamcinolone Acetonide 7.5 mg/mL

7.5 mg/mL intralesional injection

DRUG

Triamcinolone Acetonide 10 mg/mL

10 mg/mL intralesional injection

Trial Locations (1)

10021

Weill Medical College of Cornell University, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT03991936 - Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis | Biotech Hunter | Biotech Hunter